| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
22,417 |
13,729 |
$1.36M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,850 |
1,843 |
$239K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,659 |
5,362 |
$188K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,083 |
5,148 |
$118K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,768 |
1,609 |
$70K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,791 |
3,646 |
$48K |
| 64566 |
|
347 |
137 |
$35K |
| 76770 |
|
369 |
356 |
$31K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
53 |
53 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
288 |
261 |
$16K |
| 51728 |
|
37 |
37 |
$10K |
| 88312 |
|
1,818 |
1,813 |
$9K |
| 81003 |
|
4,959 |
4,720 |
$6K |
| 55700 |
|
60 |
60 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
26 |
26 |
$4K |
| 51600 |
|
25 |
25 |
$3K |
| 81001 |
|
2,203 |
2,048 |
$3K |
| 51797 |
|
25 |
25 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
178 |
171 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
34 |
28 |
$3K |
| 87486 |
|
53 |
53 |
$2K |
| 87581 |
|
53 |
53 |
$2K |
| 74455 |
|
25 |
25 |
$2K |
| 52005 |
|
13 |
13 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
53 |
53 |
$2K |
| 74420 |
|
79 |
77 |
$1K |
| 52281 |
|
16 |
16 |
$1K |
| 51784 |
|
25 |
25 |
$1K |
| 76872 |
|
48 |
48 |
$866.29 |
| 51703 |
|
29 |
27 |
$508.23 |
| 52204 |
|
12 |
12 |
$401.16 |
| 51741 |
|
25 |
25 |
$243.78 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
92 |
90 |
$87.00 |